HOME >> MEDICINE >> NEWS
Clinical study of Penn State Hershey technology begins in South Africa

The first clinical study of the neonatal chest wall stabilizer developed at Penn State Hershey Medical Center recently began at three hospitals in Johannesburg, South Africa.

Charles Palmer, M.B., Ch.B., device inventor and professor of pediatrics, Penn State College of Medicine, spent two weeks in August in South Africa where he trained medical staff to use the chest wall stabilizer, a device that allows babies with respiratory distress to breathe easier.

"Although the device could be an option for babies who need help with breathing in technologically-advanced hospitals like those in the United States, it could be particularly useful in developing countries where more expensive medical options are unavailable or in short supply," Palmer said.

The chest wall stabilizer was designed for premature babies who have underdeveloped, unstable chest walls that retract or buckle inward with each breath, making it difficult for them to breathe and get adequate oxygen. Palmer's lightweight device wraps around the chest wall and fastens to the skin of the chest and back with a non-irritating, water-soluble adhesive. The device is non-invasive, provides stability to the rib cage, restores the chest shape, permits chest expansion and has already been shown to allow easier breathing. Most importantly, this small device allows parents to hold the baby while they grow and heal.

The technology was recently patented and then licensed by Penn State to Respironics Inc., of Murraysville, Pa. Respironics is further developing it under the name, Hug 'n' Snug* Neonatal Chest Splint.

Although tested on an experimental basis in the United States, the first clinical study is taking place in South Africa where Palmer hopes the device will be available as soon as possible to help babies who do not have as many options as those in the United States. In the U.S., babies who are suffering from respiratory distress are given a substance called surfactant as well
'"/>

Contact: Valerie Gliem
vgliem@psu.edu
814-865-9481
Penn State
25-Aug-2003


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clinical study Penn State Hershey technology begins South Africa

(Date:6/19/2013)... For years, Alzheimer,s researchers have focused on two ... Alzheimer,s and may contribute to the disease: plaques made ... protein, called tau. , But for the first time, ... two proteins independently, but at the interaction of the ... tissue of post-mortem Alzheimer,s patients and in mouse brains ...
(Date:6/19/2013)... Despite the fact that the incidence of cancer is ... age, we still have an inadequate understanding on how ... though elderly patients are occasionally included in clinical trials, ... ,healthy, (fit) elderly patients. Thus, the broader elderly patient ... EORTC Cancer in the Elderly Task Force is now ...
(Date:6/19/2013)... 2013 Chicago is cracking down on bed ... 50th Chicago Wards will require landlords to exterminate any and ... The ordinance also makes tenants responsible for reporting ... requests – which often include disposing of furniture, bedding, and ... reported that it did more bed bug business in Chicago ...
(Date:6/19/2013)... The Cancer Support Community (CSC), an international nonprofit ... the whole patient with the launch today of the ... inaugural event, held at the Newseum, will feature a ... Congress members who have made a significant impact on ... currently engaged in the cancer journey. ...
(Date:6/19/2013)... June 19, 2013 A brain tumor ... those closest to them. The sudden onset of symptoms, ... tumor has on a patient’s behavioral and cognitive functions ... the patient and family. The American Brain Tumor ... 26 and Saturday, July 27 in Chicago, focuses on ...
Breaking Medicine News(10 mins):Health News:New Alzheimer's research suggests possible cause: The interaction of proteins in the brain 2Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3Health News:American Brain Tumor Association Conference Advances Holistic Approach to Living with a Brain Tumor 2Health News:American Brain Tumor Association Conference Advances Holistic Approach to Living with a Brain Tumor 3
(Date:6/18/2013)... LAVAL, Quebec , June 18, 2013 ... and TSX: VRX) (the "Company") announced today that VPII ... of the Company, has launched its offer of approximately ... (the "Notes").  The Notes will be due in 2021 ... The Company intends to use the net ...
(Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... announced public offering of common shares (the "Offering"). Pursuant ... shares at a price of $85.00 per share, for ... will file a final prospectus supplement to its effective ... a similar filing with the securities regulatory authorities in ...
(Date:6/18/2013)...  Actavis, Inc. (NYSE: ACT ) today announced ... Securities and Exchange Commission (SEC) a registration statement on Form ... Chilcott plc (NASDAQ: WCRX ), which included ... (the "Form S-4"). As previously announced on ... entered into a definitive agreement pursuant to which Actavis will ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7
Cached News: